Analysis of this tissue cohort demonstrated that overall, malignant melanomas and lymph node metastasis were extensively expressing TRPV2, while benign nevi exhibited faint or no staining (Fig 7B–D and Appendix Fig S10C). This evidence concerns the gene TRPV2 and melanoma.